A
Alan J. Freyer
Researcher at Pennsylvania State University
Publications - 147
Citations - 3714
Alan J. Freyer is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Berberidaceae & Isoquinoline. The author has an hindex of 29, co-authored 147 publications receiving 3554 citations. Previous affiliations of Alan J. Freyer include University of Santiago, Chile & Ege University.
Papers
More filters
Journal ArticleDOI
Novel Alkaloids from the Sponge Batzella sp.: Inhibitors of HIV gp120-Human CD4 Binding
Ashok D. Patil,N. Vasant Kumar,W. C. M. C. Kokke,Mark F. Bean,Alan J. Freyer,Charles De Brosse,Shing Mai,Alemseged Truneh,Brad Carte +8 more
Journal ArticleDOI
Synthesis of the tricyclic portions of batzelladines A, B and D. Revision of the stereochemistry of batzelladines A and D
TL;DR: The tricyclic portion 4 of batzelladine B (2 ) is obtained from 10a, which differs in one side chain from the ptilomycalin A model 10c that we prepared several years ago, by reduction with NaBH 3 CN in buffered MeOH as discussed by the authors.
Journal ArticleDOI
(±)-Nuevamine, an isoindoloisoquinoline alkaloid, and (±)-lennoxamine, an isoindolobenzazepine
TL;DR: Berberis darwinii Hook (Berberidaceae) has yielded the lactams (±)-nuevamine (7) and (−)-lennoxamine (8) as discussed by the authors.
Journal ArticleDOI
Frondosins, five new sesquiterpene hydroquinone derivatives with novel skeletons from the sponge Dysidea frondosa: Inhibitors of interleukin-8 receptors
Ashok D. Patil,Alan J. Freyer,Lew B. Killmer,Priscilla Offen,Brad Carte,Anthony J. Jurewicz,Randall K. Johnson +6 more
TL;DR: In this article, a bioassay-guided fractionation of the EtOAc extract of the sponge Dysidea frondosa collected in Pohnpei yielded five sesquiterpenes, frondosins A - E ( 1−5 ).
Journal ArticleDOI
New leukotriene B4 receptor antagonist : leucettamine A and related imidazole alkaloids from the marine sponge Leucetta microraphis
George Wai-Kin Chan,Seymour Mong,Mark E. Hemling,Alan J. Freyer,Priscilla Offen,Charles W. DeBrosse,Henry M. Sarau,John Westley +7 more
TL;DR: With leucettamine A identified as a pure LTB4 receptor antagonist, a new structure lead is presented to inflammation therapy.